HIGH GRADE NEUROENDOCRINE CARCINOMA, ANY SITE

Clinical trials for HIGH GRADE NEUROENDOCRINE CARCINOMA, ANY SITE explained in plain language.

Never miss a new study

Get alerted when new HIGH GRADE NEUROENDOCRINE CARCINOMA, ANY SITE trials appear

Sign up with your email to follow new studies for HIGH GRADE NEUROENDOCRINE CARCINOMA, ANY SITE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for rare, Fast-Growing tumors: First-of-its-Kind trial launches

Disease control Recruiting now

This study is testing whether a combination of two existing cancer drugs, lenvatinib and pembrolizumab, can help control a rare and aggressive type of neuroendocrine tumor. It will enroll 29 adults with a specific, fast-growing tumor type that has spread or cannot be removed by s…

Matched conditions: HIGH GRADE NEUROENDOCRINE CARCINOMA, ANY SITE

Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

HIGH GRADE NEUROENDOCRINE CARCINOMA, ANY SITE

Get alerted when new HIGH GRADE NEUROENDOCRINE CARCINOMA, ANY SITE trials appear

New hope for rare, Fast-Growing tumors: First-of-its-Kind trial launches